Abstract
BackgroundAntibody therapies can direct natural killer (NK) cells to tumor cells, tumor-associated cells, and suppressive immune cells to mediate antibody-dependent cell-mediated cytotoxicity (ADCC). This antigen-specific effector function of human NK...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have